Please enable JavaScript
Powered by Benchmark Matribhumi Samachar English - Page 264 of 2976 -
Friday, March 06 2026 | 07:55:21 PM

Kerala: Left government blocks Kumbh Mela at Thirunavaya, ignites statewide controversy over sudden permit denial

Thiruvananthapuram: Uttarkashi Juna Akhada Mutt Chief Swami Anandavanam Bharathi has sharply criticised the Left Democratic Front (LDF) government in Kerala for denying permission to hold the Maha Magha Mahotsavam, widely described as Kerala’s Kumbh Mela, at Thirunavaya Manappuram. Addressing a press conference, Swami Anandavanam Bharathi said the state government must …

Read More »

Alike Launches Customisable Digital Tourist Passes for Dubai, London, Paris and Singapore

London, United Kingdom–(Newsfile Corp. – January 14, 2026) – Alike, the AI-powered unified social travel platform, has launched its customisable digital tourist passes for Dubai, London, Paris and Singapore. The tourist passes allow travellers to build their own city itineraries instead of purchasing fixed bundles, providing greater flexibility. To view …

Read More »

Carlyle Commodities Announces Increased $3 Million Financing in Connection with Proposed Transaction with Silver Pony Resources

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia–(Newsfile Corp. – January 14, 2026) – Carlyle Commodities Corp. (CSE: CCC) (FSE: BJ4) (“Carlyle”) is pleased to announce a non-brokered private placement (the “Private Placement“) of up to $3,000,000 through the issuance …

Read More »

ReeXploration Announces Fully Funded 2026 Uranium Drill Program at Eureka, Namibia

Company prepares for initial drill program targeting high-priority uranium anomalies following financing and 2025 strategic milestones Halifax, Nova Scotia–(Newsfile Corp. – January 14, 2026) – ReeXploration Inc. (TSXV: REE) (FSE: K2I0) (“ReeXploration” or the “Company”) is pleased to announce that the 2026 uranium exploration drill program at its flagship Eureka …

Read More »

TempraMed Receives Positive Response on Payor Reimbursement Model Driving Significant Return on Investment for Medical Payor Coverage

Validation is expected to accelerate TempraMed’s path to payor reimbursement for product portfolio Highlights ROI model validated for savings and metrics by Validation Institute, a leading authority in healthcare value and economic credibility Confirms that payors covering VIVI Cap™ can achieve meaningful cost savings and return on investment Supports TempraMed’s …

Read More »